20 min listen
JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials
JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials
ratings:
Length:
3 minutes
Released:
Apr 16, 2024
Format:
Podcast episode
Description
Commentary by Corralea Kappel
Released:
Apr 16, 2024
Format:
Podcast episode
Titles in the series (100)
JACCCEP - August 2015 by JACC Specialty Journals